Literature DB >> 357162

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma--final evaluation. E.O.R.T.C. Brain Tumor Group.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 357162     DOI： 10.1016/0014-2964(78)90100-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  17 in total

1.  Pre-radiation chemotherapy in glioma patients with poor prognostic factors.

Authors:  K Watne; O Nome; B Hager; H Hirschberg
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

Review 2.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

Review 3.  Current impact of adjuvant chemotherapy in resectable cancer.

Authors:  A Rossi; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 4.  Nitrosoureas in the Management of Malignant Gliomas.

Authors:  Alba A Brandes; Marco Bartolotti; Alicia Tosoni; Enrico Franceschi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

5.  Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.

Authors:  T Trojanowski; J Peszyński; K Turowski; S Kamiński; I Gościński; M Reinfus; T Krzyszkowski; M Pyrich; A Bielawski; C Leszczyk
Journal:  J Neurooncol       Date:  1988-11       Impact factor: 4.130

6.  Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma.

Authors:  Amerigo Boiardi; Mirco Bartolomei; Antonio Silvani; Marica Eoli; Andrea Salmaggi; Elena Lamperti; Ida Milanesi; Andrea Botturi; Paola Rocca; Lisa Bodei; Giovanni Broggi; Giovanni Paganelli
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

7.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.

Authors:  R Sposto; I J Ertel; R D Jenkin; C P Boesel; J L Venes; J A Ortega; A E Evans; W Wara; D Hammond
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

Review 8.  Chemotherapy of malignant gliomas.

Authors:  Y Ushio; T Hayakawa; H Hasegawa; K Yamada; N Arita
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

9.  Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).

Authors:  M Poisson; Y Péréon; J Chiras; J Y Delattre
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

10.  The effects of local and systemic interferon beta (Fiblaferon) on supratentorial malignant cerebral glioma--a phase II study.

Authors:  K R von Wild; T H Knocke
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.